Description
Given the increasingly fierce competition in the pharmaceutical industry, innovative drug delivery systems are now the go-to approach for both new chemical entities development and refinement or repurposing of the approved drug products. Not only for the reasons of commercial concerns include intellectual property, life-cycle management, cost and market differentiation, innovative formulations also offer many more preponderances such as increasing the efficacy and duration of drug activity, improving patient compliance and reducing unwanted side effects. In this case, investigation of the novel formulation technologies can provide potential value-added opportunities for both generic drugs and innovative pharmaceuticals.